CFSAN
This article was originally published in The Tan Sheet
Executive Summary
FDA Office of Small Business, Scientific and Trade Affairs Director Mary Ann Danello began a 60-day detail in the CFSAN director's office in early November. The temporary assignment, which may be extended, is intended to fill the personnel gap created by the impending retirement of CFSAN Deputy Director Douglas Archer on Jan. 1 ("The Tan Sheet" July 26, In Brief). The search for a permanent replacement for Archer is ongoing.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning